Last update:
Coronavirus (COVID-19)
Medications
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential alternative to Paxlovid
A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in immunocompromised patients, according to Karen S. Anderson, Ph.D., professor of pharmacology and of molecular biophysics ...
1 hour ago
0
3
Medical research
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell models
Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets "Mac-1," ...
Apr 25, 2024
0
37
COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
COVID-19 research: Study reveals new details about potentially deadly inflammation
A recent USC study provides new information about why SARS-CoV-2, the virus behind the COVID-19 pandemic, may elicit mild symptoms at first but then, for a subset of patients, turn potentially fatal a week or so after infection. ...
Mar 29, 2024
0
57
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Despite huge advances in our understanding of COVID-19 over the past four years, the disease is still very much among us—and there remains a lot to learn.
Apr 24, 2024
0
28
Study sheds new light on cross-species virus spillovers that can cause pandemics
A study led by the University of Stirling jointly with the University of Wisconsin-Madison has shed new light on cross-species virus spillovers that can cause pandemics.
Apr 23, 2024
0
38
Researchers develop more broadly protective coronavirus vaccine
Scientists have been searching for the optimal coronavirus vaccine since the COVID-19 pandemic started. The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; ...
Apr 1, 2024
0
278
Common antibiotic may be helpful in fighting respiratory viral infections
A new, Yale-led study suggests that a range of respiratory viral infections—including COVID-19 and influenza—may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
Apr 22, 2024
0
98
Discovery of how COVID-19 virus replicates opens door to new antiviral therapies
A new study looking at the replication stage of the SARS-CoV-2 virus that causes COVID-19 reveals important mechanisms in its replication that could be the foundation for new antiviral therapies.
Apr 5, 2024
0
9
Asia-Pacific gets new weapon in fight against drug-resistant TB
A faster and vastly more effective treatment for drug-resistant tuberculosis is being rolled out in the Asia-Pacific region, raising hopes of a "new era" in tackling one of the world's deadliest infectious diseases.
Apr 12, 2024
0
20
Health workers fear it's profits before protection as CDC revisits airborne transmission
Four years after hospitals in New York City overflowed with COVID-19 patients, emergency physician Sonya Stokes remains shaken by how unprepared and misguided the American health system was.
Mar 21, 2024
0
0
Decreases in social disparities in air pollution during lockdown suggest the need for sustainable policies
Is everyone equally affected by environmental pollution? This is the essence of 'environmental justice,' a concept that originated in the United States during the 1970s. It revolves around the idea of ensuring fairness and ...
Mar 25, 2024
0
13
COVID-19 antibody discovery could explain long COVID
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of ...
Mar 28, 2024
0
42
Motivations for travel nurses accepting temporary assignments go beyond the big pay boost
Travel nurses take short-term contracts that can require long commutes or temporarily living away from home. Time and again, they have to get used to new co-workers, new protocols and new workplaces.
Apr 1, 2024
0
0
Hope for treating autoimmune diseases: Researchers explore diagnostic role of the systemic inflammation index
A routine blood test that measures a patient's inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.
Apr 3, 2024
0
19
Four years after shelter-in-place, COVID-19 misinformation persists
From spring break parties to Mardi Gras, many people remember the last major "normal" thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.
Apr 4, 2024
0
4
Disease severity similar for RSV as unvaccinated COVID-19, influenza
Disease severity is similar for patients hospitalized with respiratory syncytial disease (RSV) and unvaccinated adults with COVID-19 or influenza, according to a study published online April 4 in JAMA Network Open.
Apr 8, 2024
0
1
Having options can lower vaccine hesitancy, finds research
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
Study suggests staying current with COVID-19 vaccinations helps combat emerging variants
New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.
Apr 12, 2024
0
47
How can companies address consumers who are averse to products using a novel technology?
Researchers from IE Business School and Indian Institute of Management Shillong have published a new study that examines why certain consumers are averse to products using a novel technology and what strategies marketers ...
Apr 16, 2024
0
1
CEOs' human concern translates into higher stock price, says study
Compassionate leadership has tangible benefits: CEOs' expressions of empathy correlate with positive stock performance, a study led by the University of Zurich shows. The researchers analyzed data from conference calls between ...
Apr 18, 2024
0
1
